[Sulfhydryl-based treatment of rheumatoid arthritis (penicillamine, pyrithioxin, thiopronine)].
D000603:Amino Acids, Sulfur / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D010396:Penicillamine / Q000009:adverse effects / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D011746:Pyrithioxin / Q000009:adverse effects / Q000627:therapeutic use*; D013438:Sulfhydryl Compounds / Q000627:therapeutic use; D008625:Tiopronin / Q000627:therapeutic use*
D000603:Amino Acids, Sulfur; D011725:Pyridines; D013438:Sulfhydryl Compounds; D011746:Pyrithioxin; D008625:Tiopronin; D010396:Penicillamine
Les traitements de fond sulfhydrylés de la polyarthrite rhumatoïde (pénicillamine, pyrithioxine, thiopronine).